Works by Röth, Alexander

Results: 68
    1
    2
    3
    4
    5

    Telomeres and prognosis in patients with chronic lymphocytic leukaemia.

    Published in:
    2011
    By:
    • Sellmann, Ludger;
    • Beer, Dirk;
    • Bartels, Marius;
    • Opalka, Bertram;
    • Nückel, Holger;
    • Dührsen, Ulrich;
    • Dürig, Jan;
    • Seifert, Marc;
    • Siemer, Dörte;
    • Küppers, Ralf;
    • Baerlocher, Gabriela;
    • Röth, Alexander;
    • de Beer, Dirk;
    • Nückel, Holger;
    • Dührsen, Ulrich;
    • Dürig, Jan;
    • Siemer, Dörte;
    • Küppers, Ralf;
    • Baerlocher, Gabriela M;
    • Röth, Alexander
    Publication type:
    journal article
    6
    7

    Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 5, p. 2050, doi. 10.1007/s12325-024-02827-8
    By:
    • Patriquin, Christopher J.;
    • Bogdanovic, Andrija;
    • Griffin, Morag;
    • Kelly, Richard J.;
    • Maciejewski, Jaroslaw P.;
    • Mulherin, Brian;
    • Peffault de Latour, Régis;
    • Röth, Alexander;
    • Selvaratnam, Veena;
    • Szer, Jeffrey;
    • Al-Adhami, Mohammed;
    • Horneff, Regina;
    • Tan, Lisa;
    • Yeh, Michael;
    • Panse, Jens
    Publication type:
    Article
    8

    Pregnancies and Neonatal Outcomes in Patients with Sickle Cell Disease (SCD): Still a (High-)Risk Constellation?

    Published in:
    Journal of Personalized Medicine, 2021, v. 11, n. 9, p. 870, doi. 10.3390/jpm11090870
    By:
    • Proske, Pia;
    • Distelmaier, Laura;
    • Aramayo-Singelmann, Carmen;
    • Koliastas, Nikolaos;
    • Iannaccone, Antonella;
    • Papathanasiou, Maria;
    • Temme, Christian;
    • Klump, Hannes;
    • Lenz, Veronika;
    • Koldehoff, Michael;
    • Carpinteiro, Alexander;
    • Reinhardt, Hans Christian;
    • Köninger, Angela;
    • Röth, Alexander;
    • Yamamoto, Raina;
    • Dührsen, Ulrich;
    • Alashkar, Ferras
    Publication type:
    Article
    9
    10
    11
    12

    Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 9, p. 1768, doi. 10.1002/ajh.27412
    By:
    • Röth, Alexander;
    • He, Guangsheng;
    • Tong, Hongyan;
    • Lin, Zenghua;
    • Wang, Xiaoqin;
    • Chai‐Adisaksopha, Chatree;
    • Lee, Je‐Hwan;
    • Brodsky, Andres;
    • Hantaweepant, Chattree;
    • Dumagay, Teresita E.;
    • Demichelis‐Gómez, Roberta;
    • Rojnuckarin, Ponlapat;
    • Sun, Jing;
    • Höglund, Martin;
    • Jang, Jun Ho;
    • Gaya, Anna;
    • Silva, Fernando;
    • Obara, Naoshi;
    • Kelly, Richard J.;
    • Beveridge, Leigh
    Publication type:
    Article
    13
    14
    15

    Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 8, p. 1246, doi. 10.1002/ajh.26965
    By:
    • Röth, Alexander;
    • Barcellini, Wilma;
    • D'Sa, Shirley;
    • Miyakawa, Yoshitaka;
    • Broome, Catherine M.;
    • Michel, Marc;
    • Kuter, David J.;
    • Jilma, Bernd;
    • Tvedt, Tor Henrik Anderson;
    • Weitz, Ilene C.;
    • Yoo, Ronnie;
    • Jayawardene, Deepthi;
    • Vagge, Deepthi S.;
    • Kralova, Katarina;
    • Shafer, Frank;
    • Wardȩcki, Marek;
    • Lee, Michelle;
    • Berentsen, Sigbjørn
    Publication type:
    Article
    16
    17
    18
    19

    Poster: MDS-134: Efficacy and Safety at 48 Weeks of Pegcetacoplan in Adult Paroxysmal Nocturnal Hemoglobinuria Patients with Suboptimal Response to Prior Eculizumab Treatment.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S228, doi. 10.1016/S2152-2650(21)01438-5
    By:
    • Weitz, Ilene C.;
    • De Latour, Régis Peffault;
    • Szer, Jeffrey;
    • Röth, Alexander;
    • Höchsmann, Britta;
    • Panse, Jens;
    • Usuki, Kensuke;
    • Griffin, Morag;
    • Kiladjian, Jean-Jacques;
    • de Castro, Carlos M.;
    • Nishimori, Hisakazu;
    • Tan, Lisa;
    • Al-Adhami, Mohammed;
    • Deschatelets, Pascal;
    • Francois, Cedric;
    • Grossi, Federico;
    • Risitano, Antonio;
    • Hillmen, Peter
    Publication type:
    Article
    20
    21
    22
    23
    24

    Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria.

    Published in:
    Hematology, 2024, v. 29, n. 1, p. 1, doi. 10.1080/16078454.2024.2329030
    By:
    • Dingli, David;
    • De Castro III, Carlos;
    • Koprivnikar, Jamie;
    • Kulasekararaj, Austin;
    • Maciejewski, Jaroslaw;
    • Mulherin, Brian;
    • Panse, Jens;
    • Pullarkat, Vinod;
    • Röth, Alexander;
    • Shammo, Jamile;
    • Terriou, Louis;
    • Weitz, Ilene;
    • Yermilov, Irina;
    • Gibbs, Sarah;
    • Broder, Michael;
    • Beenhouwer, David;
    • Kuter, David
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Cold agglutinine disease.

    Published in:
    European Journal of Haematology, 2010, v. 84, n. 1, p. 91, doi. 10.1111/j.1600-0609.2009.01320.x
    By:
    • Röth, Alexander;
    • Dührsen, Ulrich
    Publication type:
    Article
    35
    36
    37

    Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 2, p. 373, doi. 10.1111/ejh.14339
    By:
    • Röth, Alexander;
    • Fu, Rong;
    • He, Guangsheng;
    • Alzahrani, Hazzaa;
    • Chou, Sheng‐Chieh;
    • Hicheri, Yosr;
    • Kaźmierczak, Maciej;
    • Recova, Viviane Lacorte;
    • Uchiyama, Michihiro;
    • Vladareanu, Ana‐Maria;
    • Beveridge, Leigh;
    • Buatois, Simon;
    • Buri, Muriel;
    • Compagno, Nicolo;
    • Shi, Dayu;
    • Balachandran, Nadiesh;
    • Sreckovic, Sasha;
    • Scheinberg, Phillip
    Publication type:
    Article
    38
    39
    40

    Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long‐term results from the phase I/II COMPOSER trial.

    Published in:
    European Journal of Haematology, 2023, v. 111, n. 2, p. 300, doi. 10.1111/ejh.14011
    By:
    • Röth, Alexander;
    • Ichikawa, Satoshi;
    • Ito, Yoshikazu;
    • Kim, Jin Seok;
    • Nagy, Zsolt;
    • Obara, Naoshi;
    • Panse, Jens;
    • Schrezenmeier, Hubert;
    • Sica, Simona;
    • Soret, Juliette;
    • Usuki, Kensuke;
    • Yoon, Sung‐Soo;
    • Balachandran, Nadiesh;
    • Buri, Muriel;
    • Lundberg, Pontus;
    • Patel, Himika;
    • Shinomiya, Kenji;
    • Sostelly, Alexandre;
    • Nishimura, Jun‐ichi
    Publication type:
    Article
    41
    42

    Sutimlimab provides clinically meaningful improvements in patient‐reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo‐controlled, Phase 3 CADENZA study.

    Published in:
    European Journal of Haematology, 2023, v. 110, n. 3, p. 280, doi. 10.1111/ejh.13903
    By:
    • Röth, Alexander;
    • Broome, Catherine M.;
    • Barcellini, Wilma;
    • Jilma, Bernd;
    • Hill, Quentin A.;
    • Cella, David;
    • Tvedt, Tor Henrik Anderson;
    • Yamaguchi, Masaki;
    • Lee, Michelle;
    • Shafer, Frank;
    • Wardęcki, Marek;
    • Jiang, Xiaoyu;
    • Patel, Parija;
    • Joly, Florence;
    • Weitz, Ilene C.
    Publication type:
    Article
    43
    44

    Acquired aplastic anemia following SARS‐CoV‐2 vaccination.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 2, p. 186, doi. 10.1111/ejh.13788
    By:
    • Röth, Alexander;
    • Bertram, Stefanie;
    • Schroeder, Thomas;
    • Haverkamp, Thomas;
    • Voigt, Sebastian;
    • Holtkamp, Caroline;
    • Klump, Hannes;
    • Wörmann, Bernhard;
    • Reinhardt, Hans Christian;
    • Alashkar, Ferras
    Publication type:
    Article
    45

    One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab.

    Published in:
    European Journal of Haematology, 2021, v. 106, n. 3, p. 389, doi. 10.1111/ejh.13564
    By:
    • Kulasekararaj, Austin G.;
    • Hill, Anita;
    • Langemeijer, Saskia;
    • Wells, Richard;
    • González Fernández, F. Ataúlfo;
    • Gaya, Anna;
    • Ojeda Gutierrez, Emilio;
    • Piatek, Caroline I.;
    • Mitchell, Lindsay;
    • Usuki, Kensuke;
    • Bosi, Alberto;
    • Brodsky, Robert A.;
    • Ogawa, Masayo;
    • Yu, Ji;
    • Ortiz, Stephan;
    • Röth, Alexander;
    • Lee, Jong Wook;
    • Peffault de Latour, Régis
    Publication type:
    Article
    46

    Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria.

    Published in:
    Annals of Hematology, 2025, v. 104, n. 1, p. 81, doi. 10.1007/s00277-025-06193-5
    By:
    • Kulasekararaj, Austin;
    • Brodsky, Robert;
    • Schrezenmeier, Hubert;
    • Griffin, Morag;
    • Röth, Alexander;
    • Piatek, Caroline;
    • Ogawa, Masayo;
    • Yu, Ji;
    • Patel, Ami S.;
    • Patel, Yogesh;
    • Notaro, Rosario;
    • Usuki, Kensuke;
    • Kulagin, Alexander;
    • Gualandro, Sandra;
    • Füreder, Wolfgang;
    • Peffault de Latour, Regis;
    • Szer, Jeff;
    • Lee, Jong Wook
    Publication type:
    Article
    47
    48
    49
    50